½ÃÇè°ú¸ñº° °øÁö»çÇ×

  • ½ÃÇè¾È³»
  • ½ÃÇè°ú¸ñº° °øÁö»çÇ×

2025³âµµ Á¦3ȸ Àü¹®¾à»ç ÀڰݽÃÇè °øÁö»çÇ×

- ¼Ò¾Æ -

1½ÃÇè³»¿ë ±¸¼º ¹× ½ÃÇè½Ã°£ (Àü °ú¸ñ °øÅë»çÇ×)

1)½ÃÇè³»¿ëÀº °øÅ뿵¿ª°ú Àü¹®¿µ¿ªÀ¸·Î ±¸¼ºµÊ.

  • °øÅ뿵¿ª : ÀÇÇÐÅë°è ¹× ÀǤý¾àÇÐ³í¹®ºñÆò
  • Àü¹®¿µ¿ª : ¼Ò¾Æ

2)½ÃÇè½Ã°£

  • ÃÑ ½ÃÇè½Ã°£ : ½ÃÇèÁغñ ¹× ¾È³», °øÁö½Ã°£ µîÀ» Æ÷ÇÔÇÏ¿© 180ºÐ(3½Ã°£).

2ÃâÁ¦À¯Çü ¹× ¹èÁ¡

1)°øÅ뿵¿ª(ÃÑ20Á¡) : °´°ü½Ä 20¹®Ç× (°¢ 1Á¡)

2)Àü¹®¿µ¿ª(ÃÑ80Á¡) : °´°ü½Ä 80¹®Ç× (°¢ 1Á¡)

  • ¾à¹°¿ä¹ýÀÇ ÀûÀý¼º °ËÅä
  • ¾à¹°¿ä¹ý °ü·Ã ¹®Á¦(drug-related problems) ÆÄ¾Ç ¹× ÇØ°á¹æ¾È Á¦½Ã
  • ȯÀÚ ¸ÂÃãÇü ¾à¹° ¼±Åà ¹× ¾à¹°¿ä¹ý °èȹ ¼ö¸³
  • ¾à¹°¿ä¹ýÀÇ Ä¡·áÈ¿°ú ¹× ¾à¹° ÀÌ»ó¹ÝÀÀ ¸ð´ÏÅ͸µ
  • ȯÀÚ º¹¾à»ó´ã ¹× ±³À°

3ÃâÁ¦¹üÀ§

1)°øÅ뿵¿ª ÃâÁ¦¹üÀ§ : ÀǾàÅë°èÀÇ ±âº»°³³ä ¹× À̸¦ Ȱ¿ëÇÑ ³í¹®Çؼ®°ú ºñÆò, ÀÓ»óÀû¿ë µî¿¡ °üÇÑ ¹®Ç×À¸·Î ÀÌ·ç¾îÁü.

  • ±Ù°Å±â¹ÝÀÇÇÐ(Evidence-Based Medicine) ¹× ±Ù°Å±â¹ÝÀÓ»ó½Ç¹«(Evidence-Based Clinical Practice, EBCP)ÀÇ ÀÌÇØ
  • ÀǾ๮ÇåÀÇ Á¾·ù ¹× Ư¡
  • ÀÓ»óÅë°èÀÇ ±âº» °³³ä
  • ³í¹®Çؼ®°ú ºñÆò, ÀÓ»óÀû¿ë

2)Àü¹®¿µ¿ª ÃâÁ¦¹üÀ§

  • ¼Ò¾Æ¾à·á °³·Ð
    • ¼Ò¾ÆÀÇ ¼ºÀå°ú ¹ß´Þ, ½Åü°Ë»ç ¹× ÀÓ»ó°Ë»ç °á°úÀÇ ÇØ¼®, ¼Ò¾Æ ¾à¹°¿ä¹ýÀÇ Æ¯¼º ¹× ÁÖÀÇ»çÇ×, ¼Ò¾ÆÀÇ ¾ÈÀüÇÑ ¾à¹° »ç¿ë, ¼Ò¾Æ ¹× º¸È£ÀÚ¿Í ÀÇ»ç¼ÒÅë µî
  • ¼Ò¾Æ ÀÓ»ó¾àµ¿¼­ºñ½º
    • ¼Ò¾ÆÀÇ ¾àµ¿ÇÐÀû/¾à·ÂÇÐÀû Ư¼º, Ç÷Á߾๰³óµµ¸ð´ÏÅ͸µÀ» ÅëÇÑ ÀÓ»ó¾àµ¿¼­ºñ½º
  • ½Å»ý¾ÆÁßȯÀÚ ¾à·á
    • È£Èí°ï¶õÁõÈıº, ±â°üÁöÆóÀÌÇü¼ºÁõ, µ¿¸Æ°ü°³Á¸Áõ, ±«»ç¼ÒÀå´ëÀå¿°, ÆÐÇ÷Áõ, ¹«È£Èí µî
  • ¼Ò¾ÆÁßȯÀÚ ¾à·á
    • ¼îÅ©, ÁøÁ¤, ÅëÁõ, ½Å°æ±Ù Â÷´Ü, ±Þ¼ºÈ£Èí°ï¶õÁõÈıº, Æó·Å, ü¿Ü¸·»ê¼ÒÈ­¿ä¹ý µî
  • ¼Ò¾Æ Àå±âÀÌ½Ä ¾à·á
    • Àå±âÀ̽ÄÀ» ¹ÞÀº ¼Ò¾ÆÈ¯ÀÚÀÇ ¾à¹° ¿ä¹ý
  • ¼Ò¾ÆÀÇ ¼ö¾×, ÀüÇØÁú, ¿µ¾ç ¿ä¹ý
    • ¿¬·Éº° ü¾× ±¸¼º, ¼ö¾× ¹× ÀüÇØÁú ±ÕÇü, ¿µ¾ç Æò°¡, ¿µ¾ç °ø±Þ·® »êÁ¤, °æÀå ¿µ¾ç, Á¤¸Æ ¿µ¾ç, Á¤¸Æ ¿µ¾ç °ü·Ã ÇÕº´Áõ µî
  • ¼Ò¾Æ ÁÖ¿äÁúȯÀÇ ¾à·á
    • ½ÉÇ÷°ü Áúȯ: °¡¿Í»çŰº´, ¼Ò¾Æ °íÇ÷¾Ð, ¼±Ãµ¼º ½ÉÀåÁúȯ, Æó°íÇ÷¾Ð µî
    • ³»ºÐºñ ¹× ´ë»ç Áúȯ: ¼Ò¾Æ ´ç´¢, ºñ¸¸, °©»ó¼± Áúȯ, ºÎ½Å ºÎÀü, ¿äºØÁõ, Æä´ÒÄÉÅæ´¢Áõ, ¼ºÁ¶¼÷Áõ µî
    • ¼ÒÈ­±â Áúȯ: À§½Äµµ¿ª·ùÁúȯ, ¼³»ç, º¯ºñ, °ú¹Î¼º´ëÀåÁõÈıº, ¿°Áõ¼ºÀåÁúȯ, ´ÜÀåÁõÈıº µî
    • ¸é¿ª Áúȯ: ¼Ò¾Æ ¾à¹°¾Ë·¹¸£±â, ¼Ò¾Æ È£Èí±â¾Ë·¹¸£±â, ¾ÆÅäÇÇÇǺο° µî
    • ½ÅÀåÁúȯ: ¼Ò¾Æ ½Å±â´É Æò°¡, ½ÅÁõÈıº, ¼ö½ÅÁõ, ¿ëÇ÷¼º¿äµ¶ÁõÈıº µî
    • °¨¿°Áúȯ: ±Þ¼º ÁßÀÌ¿°, È£Èí±â °¨¿°, ÁßÃ߽Űæ°è °¨¿°, ¿ä·Î°¨¿°, Ç÷·ù °¨¿°, ½É³»¸·¿°, Áø±Õ °¨¿°, °áÇÙ, ¼±Ãµ¼º °¨¿° µî
    • ½Å°æÁ¤½Å°è Áúȯ: ¼Ò¾Æ ³úÀüÁõ, ÁÖÀǷ°áÇÌ °úÀ×ÇൿÀå¾Ö, ÆíµÎÅë µî
    • Ç÷¾×Á¾¾çÁúȯ
  • ¼Ò¾Æ ¿¹¹æÁ¢Á¾
    • ¼Ò¾Æ ¿¹¹æÁ¢Á¾ Áöħ, Ư¼ö »óȲ¿¡¼­ÀÇ ¿¹¹æÁ¢Á¾

4Âü°í¹®Çå

1)Àü °ú¸ñ °øÅë Âü°í¹®Çå

°¡)¾à¹°Ä¡·áÇÐ °ü·Ã Âü°í¹®Çå

  • DiPiro JT, Yee GC, Haines ST, Nolin TD, Ellingrod VL, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. 12th ed., 2023.
  • Schwinghammer TL, Koehler JM, Borchert JS, Slain D, Park SK, eds. Pharmacotherapy Casebook: A Patient-Focused Approach. 12th ed., 2023.
  • Zeind CS, Carvalho MG, Cheng JW, Zaiken K, LaPointe T, eds. Applied Therapeutics: The Clinical Use of Drugs. 12th ed., 2023.
  • Chisholm-Burns MA, Schwinghammer TL, Malone PM, Kolesar JM, Bookstaver PB, Lee KC. Pharmacotherapy Principles & Practice. 6th ed., 2022.
  • Çѱ¹ÀÓ»ó¾àÇÐȸ. ¾à¹°Ä¡·áÇÐ Á¦6°³Á¤. ½ÅÀϺϽº. 2025

³ª)°øÅ뿵¿ª(ÀÇÇÐÅë°è ¹× ÀǤý¾àÇÐ³í¹®ºñÆò) °ü·Ã Âü°í¹®Çå

  • ¾à±¹½Ç¹«ºÐ°úȸ, ¾à·áÁ¤º¸ÇÐ, ½ÅÀϺϽº, 2021³â, Section III, Á¦ 9-13Àå, 16Àå
  • ¾à±¹½Ç¹«ºÐ°úȸ, ÀÓ»ó½Ç¹«¾àÇÐ, ½ÅÀϺϽº, 2024³â, 27Àå, 29Àå
  • Guyatt G, Rennie D, Meade MO & Cook DJ. Users¡¯ Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 3rd ed., New York, USA: McGraw Hill Education & The JAMA Network. 2015.
  • DiCenzo R, ed. Clinical Pharmacist's Guide to Biostatistics and Literature Evaluation. 2nd ed., Lenexa, KS, USA: American College of Clinical Pharmacy. 2015.
  • Browner WS, Thomas B Newman TB, Cummings SR. Designing Clinical Research. 5th ed. Wolters Kluwer. 2022.
  • Malone PM, Witt BA, Malone MJ, Peterson DM. Drug Information: A Guide for Pharmacists, 7th ed. McGraw Hill. 2022.
  • Canadian Medical Association Journal (CMAJ) evidence based medicine (EBM) series
    • Wyer PC, et al. Tips for learning and teaching evidence-based medicine: Introduction to the series. CMAJ 2004;171:347-8.
    • Barratt A, et al. Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat. CMAJ 2004;171:353-8.
    • Montoria VM, et al. Tips for learners of evidence-based medicine: 2. Measures of precision (confidence intervals). CMAJ 2005;171:611-5.

2)Àü¹®¿µ¿ª °ü·Ã Âü°í¹®Çå

  • Benavides S, Nahata MC, eds. Pediatric Pharmacotherapy, ACCP, 2020
  • ¾ÈÈ¿¼·, ½ÅÈñ¿µ. ȫâÀÇ ¼Ò¾Æ°úÇÐ, 12ÆÇ
  • Kliegman, Robert M., Nelson Textbook of Pediatrics. 22nd ed., Elsevier, 2024
  • Murphy JE. Clinical pharmacokinetics. 7th ed., ASHP, 2022
  • ´ëÇѽŻý¾ÆÇÐȸ, ½Å»ý¾ÆÁø·áÁöħ, Á¦4ÆÇ
  • °ü·Ã °¡À̵å¶óÀÎ ÂüÁ¶
    • American Academy of Pediatrics (AAP) Website. http://www.aap.org
    • European Society for Clinical Nutrition and Metabolism (ESPEN) Website. https://www.espen.org
    • American Society for Parenteral & Enteral Nutrition (ASPEN) Website. http://nutritioncare.org